Torsemide Tablets — Class II drug recall D-0244-2017
Terminated recall by Apotex Corp., reported 2017-01-11. CGMP Deviations
| Recall number | D-0244-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Corp., Weston, FL, United States |
| Recall initiated | 2016-12-14 |
| Classified | 2017-01-02 |
| Reported by FDA | 2017-01-11 |
| Terminated | 2022-06-15 |
| Reason classes | cgmp |
| NDC | 60505-0234-01 |
| Lot numbers | 01/17, KT5981, KT5982, KT5983 |
Product
Torsemide Tablets, 20 mg 100-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9W, 6Y3, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0234-01
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0244-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.